Founded In 2014Annji Pharmaceutical Co Ltd Annjiis An R&D Basedclinical Stage New Drug Company Dedicated To The Development Of First In Class Small Molecules Focusing On Indications With Highly Unmet Needs In The Therapeutic Areas Of Neurologydermatologyand Inflammatory Disordersincluding Rare Diseases Such As Idiopathic Pulmonary Fibrosis And Kennedy S Diseaseor Sbmaspinal And Bulbar Muscular Atrophyour Goals Are To Translate And Develop Uniqueinnovativeand Highly Differentiated Drug Therapies And To Engage Global Collaborators And Business Partners In Late Stage Product Development And Commercialization
